Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device offers hope for chest pain sufferers with Hard-to-Treat heart condition

NCT ID NCT06991322

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This early study tests a device called the A-FLUX Reducer, placed in a heart vein to improve blood flow and reduce chest pain in people with coronary microvascular dysfunction (CMD). About 30 adults with persistent symptoms despite standard treatments will take part. The goal is to see if the device is safe and can ease symptoms, not to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY MICROVASCULAR DYSFUNCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Clínic Barcelona

    RECRUITING

    Barcelona, Spain

    Contact

  • University Medical Center Utrecht

    RECRUITING

    Utrecht, 3584, Netherlands

    Contact

  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu

    RECRUITING

    Warsaw, Poland

    Contact

Conditions

Explore the condition pages connected to this study.